Cargando…
Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens
IMPORTANCE: Tumor mutation burden (TMB) is an emerging factor associated with survival with immunotherapy. When tumor-normal pairs are available, TMB is determined by calculating the difference between somatic and germline sequences. In the case of commonly used tumor-only sequencing, additional ste...
Autores principales: | Parikh, Kaushal, Huether, Robert, White, Kevin, Hoskinson, Derick, Beaubier, Nike, Dong, Haidong, Adjei, Alex A., Mansfield, Aaron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049088/ https://www.ncbi.nlm.nih.gov/pubmed/32108894 http://dx.doi.org/10.1001/jamanetworkopen.2020.0202 |
Ejemplares similares
-
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups
por: Asmann, Yan W., et al.
Publicado: (2021) -
A Clinical Approach to Detecting Germline Pathogenic Variants From Tumor-Only Sequencing
por: Ceyhan-Birsoy, PhD, Ozge, et al.
Publicado: (2020) -
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
por: Terraf, P., et al.
Publicado: (2022) -
Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing
por: Jalloul, Nahed, et al.
Publicado: (2021) -
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor
por: Schienda, Jaclyn, et al.
Publicado: (2021)